Clinical Trial

Phenotyping and Classifying Asthma Exacerbations

Study acronym: ExCluSieF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
An observational study in patients between 12 and 70 years old with an acute asthma exacerbation, to determine the relation between phenotypical characteristics and the treatment response.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-22; most recent amendment 2025-08-20.
Status change: Recruiting → Active, Not Recruiting 2025-08-20
Status change: Not Yet Recruiting → Recruiting 2022-12-06
Trial Details
NCT Number NCT05304039
Lead Sponsor Franciscus Gasthuis
Collaborators: Erasmus Medical Center, TNO
Conditions Asthma Attack
Enrollment 200 participants
Start Date 2022-09-28
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-21